nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—ABCB1—colon cancer	0.334	1	CbGaD
Risperidone—CYP3A7—Irinotecan—colon cancer	0.0478	0.145	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0478	0.145	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0418	0.127	CbGbCtD
Risperidone—CYP3A7—Vincristine—colon cancer	0.0418	0.127	CbGbCtD
Risperidone—CYP3A5—Irinotecan—colon cancer	0.0359	0.109	CbGbCtD
Risperidone—CYP3A5—Vincristine—colon cancer	0.0314	0.0954	CbGbCtD
Risperidone—ABCB1—Irinotecan—colon cancer	0.0234	0.071	CbGbCtD
Risperidone—ABCB1—Vincristine—colon cancer	0.0204	0.0621	CbGbCtD
Risperidone—CYP3A4—Irinotecan—colon cancer	0.014	0.0425	CbGbCtD
Risperidone—ABCB1—Methotrexate—colon cancer	0.0124	0.0376	CbGbCtD
Risperidone—CYP3A4—Vincristine—colon cancer	0.0122	0.0372	CbGbCtD
Risperidone—HTR7—myenteric nerve plexus—colon cancer	0.00926	0.116	CbGeAlD
Risperidone—HTR7—vein—colon cancer	0.00597	0.0745	CbGeAlD
Risperidone—HTR2A—myenteric nerve plexus—colon cancer	0.00577	0.0721	CbGeAlD
Risperidone—HTR2A—vein—colon cancer	0.00372	0.0465	CbGeAlD
Risperidone—HTR1B—blood vessel—colon cancer	0.00245	0.0307	CbGeAlD
Risperidone—HTR1D—blood vessel—colon cancer	0.00238	0.0297	CbGeAlD
Risperidone—HTR7—endothelium—colon cancer	0.00205	0.0256	CbGeAlD
Risperidone—HTR7—blood vessel—colon cancer	0.00189	0.0236	CbGeAlD
Risperidone—H1F0—embryo—colon cancer	0.00183	0.0229	CbGeAlD
Risperidone—ADRA1B—renal system—colon cancer	0.00147	0.0183	CbGeAlD
Risperidone—H1F0—smooth muscle tissue—colon cancer	0.00144	0.018	CbGeAlD
Risperidone—H1F0—renal system—colon cancer	0.00139	0.0173	CbGeAlD
Risperidone—HTR2A—endothelium—colon cancer	0.00128	0.016	CbGeAlD
Risperidone—HTR2A—blood vessel—colon cancer	0.00118	0.0147	CbGeAlD
Risperidone—H1F0—lymphoid tissue—colon cancer	0.00115	0.0144	CbGeAlD
Risperidone—CYP3A7—liver—colon cancer	0.00114	0.0143	CbGeAlD
Risperidone—H1F0—digestive system—colon cancer	0.00114	0.0142	CbGeAlD
Risperidone—H1F0—bone marrow—colon cancer	0.00105	0.0131	CbGeAlD
Risperidone—HTR2B—smooth muscle tissue—colon cancer	0.00104	0.0129	CbGeAlD
Risperidone—H1F0—vagina—colon cancer	0.001	0.0125	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—liver—colon cancer	0.000971	0.0121	CbGeAlD
Risperidone—HTR7—epithelium—colon cancer	0.000921	0.0115	CbGeAlD
Risperidone—HTR1A—renal system—colon cancer	0.000894	0.0112	CbGeAlD
Risperidone—ADRA1A—epithelium—colon cancer	0.000889	0.0111	CbGeAlD
Risperidone—HTR7—smooth muscle tissue—colon cancer	0.000888	0.0111	CbGeAlD
Risperidone—HTR7—renal system—colon cancer	0.000855	0.0107	CbGeAlD
Risperidone—H1F0—liver—colon cancer	0.000846	0.0106	CbGeAlD
Risperidone—ADRA1A—renal system—colon cancer	0.000824	0.0103	CbGeAlD
Risperidone—HTR2B—digestive system—colon cancer	0.000819	0.0102	CbGeAlD
Risperidone—KCNH2—renal system—colon cancer	0.000796	0.00994	CbGeAlD
Risperidone—ADRA2C—renal system—colon cancer	0.000786	0.00981	CbGeAlD
Risperidone—ABCB1—blood vessel—colon cancer	0.000774	0.00966	CbGeAlD
Risperidone—HTR2B—vagina—colon cancer	0.000723	0.00903	CbGeAlD
Risperidone—HTR2A—embryo—colon cancer	0.000704	0.00879	CbGeAlD
Risperidone—HTR7—digestive system—colon cancer	0.000701	0.00875	CbGeAlD
Risperidone—HRH1—epithelium—colon cancer	0.000688	0.00859	CbGeAlD
Risperidone—ADRA1A—lymphoid tissue—colon cancer	0.000685	0.00855	CbGeAlD
Risperidone—HRH1—smooth muscle tissue—colon cancer	0.000663	0.00828	CbGeAlD
Risperidone—CYP3A5—renal system—colon cancer	0.000658	0.00821	CbGeAlD
Risperidone—H1F0—lymph node—colon cancer	0.000649	0.0081	CbGeAlD
Risperidone—KCNH2—bone marrow—colon cancer	0.000602	0.00752	CbGeAlD
Risperidone—KCNH2—vagina—colon cancer	0.000577	0.0072	CbGeAlD
Risperidone—HTR2A—epithelium—colon cancer	0.000575	0.00718	CbGeAlD
Risperidone—ADRA2C—vagina—colon cancer	0.000569	0.00711	CbGeAlD
Risperidone—HTR2A—smooth muscle tissue—colon cancer	0.000554	0.00691	CbGeAlD
Risperidone—CYP3A5—digestive system—colon cancer	0.000539	0.00673	CbGeAlD
Risperidone—HTR2A—renal system—colon cancer	0.000533	0.00666	CbGeAlD
Risperidone—HRH1—digestive system—colon cancer	0.000523	0.00654	CbGeAlD
Risperidone—HTR7—liver—colon cancer	0.000522	0.00652	CbGeAlD
Risperidone—ADRA1A—liver—colon cancer	0.000504	0.00629	CbGeAlD
Risperidone—CYP3A4—renal system—colon cancer	0.000493	0.00616	CbGeAlD
Risperidone—CYP2D6—renal system—colon cancer	0.000486	0.00606	CbGeAlD
Risperidone—ADRA2C—liver—colon cancer	0.00048	0.00599	CbGeAlD
Risperidone—CYP3A5—vagina—colon cancer	0.000476	0.00595	CbGeAlD
Risperidone—HTR2B—lymph node—colon cancer	0.000468	0.00584	CbGeAlD
Risperidone—HRH1—vagina—colon cancer	0.000462	0.00577	CbGeAlD
Risperidone—ABCB1—embryo—colon cancer	0.000461	0.00576	CbGeAlD
Risperidone—ADRA2A—vagina—colon cancer	0.000454	0.00567	CbGeAlD
Risperidone—HTR2A—digestive system—colon cancer	0.000437	0.00546	CbGeAlD
Risperidone—CYP3A4—digestive system—colon cancer	0.000405	0.00505	CbGeAlD
Risperidone—CYP3A5—liver—colon cancer	0.000402	0.00502	CbGeAlD
Risperidone—CYP2D6—digestive system—colon cancer	0.000398	0.00497	CbGeAlD
Risperidone—HTR2A—vagina—colon cancer	0.000386	0.00482	CbGeAlD
Risperidone—ABCB1—epithelium—colon cancer	0.000377	0.0047	CbGeAlD
Risperidone—KCNH2—lymph node—colon cancer	0.000373	0.00466	CbGeAlD
Risperidone—ADRA2C—lymph node—colon cancer	0.000368	0.0046	CbGeAlD
Risperidone—ABCB1—renal system—colon cancer	0.000349	0.00436	CbGeAlD
Risperidone—HTR2A—liver—colon cancer	0.000326	0.00407	CbGeAlD
Risperidone—CYP3A4—liver—colon cancer	0.000302	0.00377	CbGeAlD
Risperidone—HRH1—lymph node—colon cancer	0.000299	0.00373	CbGeAlD
Risperidone—CYP2D6—liver—colon cancer	0.000297	0.00371	CbGeAlD
Risperidone—ADRA2A—lymph node—colon cancer	0.000294	0.00367	CbGeAlD
Risperidone—ABCB1—lymphoid tissue—colon cancer	0.00029	0.00362	CbGeAlD
Risperidone—ABCB1—digestive system—colon cancer	0.000286	0.00358	CbGeAlD
Risperidone—ABCB1—bone marrow—colon cancer	0.000264	0.0033	CbGeAlD
Risperidone—ABCB1—vagina—colon cancer	0.000253	0.00316	CbGeAlD
Risperidone—ABCB1—liver—colon cancer	0.000213	0.00267	CbGeAlD
Risperidone—Oedema—Fluorouracil—colon cancer	0.000202	0.000791	CcSEcCtD
Risperidone—Anaphylactic shock—Fluorouracil—colon cancer	0.000202	0.000791	CcSEcCtD
Risperidone—Anorexia—Irinotecan—colon cancer	0.000201	0.000787	CcSEcCtD
Risperidone—Ataxia—Methotrexate—colon cancer	0.000201	0.000787	CcSEcCtD
Risperidone—Infection—Fluorouracil—colon cancer	0.000201	0.000786	CcSEcCtD
Risperidone—Haemoglobin—Capecitabine—colon cancer	0.0002	0.000782	CcSEcCtD
Risperidone—Rhinitis—Capecitabine—colon cancer	0.0002	0.00078	CcSEcCtD
Risperidone—Haemorrhage—Capecitabine—colon cancer	0.000199	0.000778	CcSEcCtD
Risperidone—Hepatitis—Capecitabine—colon cancer	0.000199	0.000778	CcSEcCtD
Risperidone—Nervous system disorder—Fluorouracil—colon cancer	0.000198	0.000776	CcSEcCtD
Risperidone—Thrombocytopenia—Fluorouracil—colon cancer	0.000198	0.000775	CcSEcCtD
Risperidone—Hypoaesthesia—Capecitabine—colon cancer	0.000198	0.000774	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000198	0.000773	CcSEcCtD
Risperidone—Pharyngitis—Capecitabine—colon cancer	0.000198	0.000772	CcSEcCtD
Risperidone—Tachycardia—Fluorouracil—colon cancer	0.000197	0.000772	CcSEcCtD
Risperidone—Hypotension—Irinotecan—colon cancer	0.000197	0.000772	CcSEcCtD
Risperidone—Urinary tract disorder—Capecitabine—colon cancer	0.000197	0.000768	CcSEcCtD
Risperidone—Insomnia—Vincristine—colon cancer	0.000196	0.000767	CcSEcCtD
Risperidone—Oedema peripheral—Capecitabine—colon cancer	0.000196	0.000767	CcSEcCtD
Risperidone—Connective tissue disorder—Capecitabine—colon cancer	0.000196	0.000765	CcSEcCtD
Risperidone—Urethral disorder—Capecitabine—colon cancer	0.000195	0.000763	CcSEcCtD
Risperidone—Paraesthesia—Vincristine—colon cancer	0.000195	0.000762	CcSEcCtD
Risperidone—Breast disorder—Methotrexate—colon cancer	0.000194	0.000757	CcSEcCtD
Risperidone—Anorexia—Fluorouracil—colon cancer	0.000193	0.000754	CcSEcCtD
Risperidone—Visual impairment—Capecitabine—colon cancer	0.000192	0.00075	CcSEcCtD
Risperidone—Insomnia—Irinotecan—colon cancer	0.000191	0.000747	CcSEcCtD
Risperidone—Paraesthesia—Irinotecan—colon cancer	0.00019	0.000742	CcSEcCtD
Risperidone—Hypotension—Fluorouracil—colon cancer	0.000189	0.000739	CcSEcCtD
Risperidone—Decreased appetite—Vincristine—colon cancer	0.000189	0.000737	CcSEcCtD
Risperidone—Dyspnoea—Irinotecan—colon cancer	0.000188	0.000736	CcSEcCtD
Risperidone—Erythema multiforme—Capecitabine—colon cancer	0.000188	0.000736	CcSEcCtD
Risperidone—Somnolence—Irinotecan—colon cancer	0.000188	0.000734	CcSEcCtD
Risperidone—Gastrointestinal disorder—Vincristine—colon cancer	0.000187	0.000732	CcSEcCtD
Risperidone—Fatigue—Vincristine—colon cancer	0.000187	0.000731	CcSEcCtD
Risperidone—Eye disorder—Capecitabine—colon cancer	0.000186	0.000727	CcSEcCtD
Risperidone—Dyspepsia—Irinotecan—colon cancer	0.000186	0.000727	CcSEcCtD
Risperidone—Tinnitus—Capecitabine—colon cancer	0.000186	0.000725	CcSEcCtD
Risperidone—Pain—Vincristine—colon cancer	0.000186	0.000725	CcSEcCtD
Risperidone—Constipation—Vincristine—colon cancer	0.000186	0.000725	CcSEcCtD
Risperidone—Asthma—Methotrexate—colon cancer	0.000185	0.000724	CcSEcCtD
Risperidone—Flushing—Capecitabine—colon cancer	0.000185	0.000722	CcSEcCtD
Risperidone—Cardiac disorder—Capecitabine—colon cancer	0.000185	0.000722	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000184	0.000721	CcSEcCtD
Risperidone—Decreased appetite—Irinotecan—colon cancer	0.000184	0.000718	CcSEcCtD
Risperidone—Insomnia—Fluorouracil—colon cancer	0.000183	0.000716	CcSEcCtD
Risperidone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000182	0.000713	CcSEcCtD
Risperidone—Fatigue—Irinotecan—colon cancer	0.000182	0.000712	CcSEcCtD
Risperidone—Paraesthesia—Fluorouracil—colon cancer	0.000182	0.00071	CcSEcCtD
Risperidone—Pancreatitis—Methotrexate—colon cancer	0.000181	0.00071	CcSEcCtD
Risperidone—Constipation—Irinotecan—colon cancer	0.000181	0.000706	CcSEcCtD
Risperidone—Pain—Irinotecan—colon cancer	0.000181	0.000706	CcSEcCtD
Risperidone—Angiopathy—Capecitabine—colon cancer	0.000181	0.000706	CcSEcCtD
Risperidone—Dyspnoea—Fluorouracil—colon cancer	0.00018	0.000705	CcSEcCtD
Risperidone—Somnolence—Fluorouracil—colon cancer	0.00018	0.000703	CcSEcCtD
Risperidone—Immune system disorder—Capecitabine—colon cancer	0.00018	0.000703	CcSEcCtD
Risperidone—Mediastinal disorder—Capecitabine—colon cancer	0.000179	0.000701	CcSEcCtD
Risperidone—Chills—Capecitabine—colon cancer	0.000179	0.000698	CcSEcCtD
Risperidone—Dyspepsia—Fluorouracil—colon cancer	0.000178	0.000696	CcSEcCtD
Risperidone—Arrhythmia—Capecitabine—colon cancer	0.000178	0.000695	CcSEcCtD
Risperidone—Abdominal discomfort—Methotrexate—colon cancer	0.000177	0.000694	CcSEcCtD
Risperidone—Gastrointestinal pain—Vincristine—colon cancer	0.000177	0.000694	CcSEcCtD
Risperidone—Decreased appetite—Fluorouracil—colon cancer	0.000176	0.000688	CcSEcCtD
Risperidone—Alopecia—Capecitabine—colon cancer	0.000176	0.000688	CcSEcCtD
Risperidone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000175	0.000683	CcSEcCtD
Risperidone—Mental disorder—Capecitabine—colon cancer	0.000174	0.000682	CcSEcCtD
Risperidone—Feeling abnormal—Irinotecan—colon cancer	0.000174	0.000681	CcSEcCtD
Risperidone—Malnutrition—Capecitabine—colon cancer	0.000173	0.000677	CcSEcCtD
Risperidone—Erythema—Capecitabine—colon cancer	0.000173	0.000677	CcSEcCtD
Risperidone—Dysuria—Methotrexate—colon cancer	0.000173	0.000677	CcSEcCtD
Risperidone—Neutropenia—Methotrexate—colon cancer	0.000173	0.000677	CcSEcCtD
Risperidone—Pain—Fluorouracil—colon cancer	0.000173	0.000677	CcSEcCtD
Risperidone—Gastrointestinal pain—Irinotecan—colon cancer	0.000173	0.000675	CcSEcCtD
Risperidone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000172	0.000673	CcSEcCtD
Risperidone—Abdominal pain—Vincristine—colon cancer	0.000171	0.00067	CcSEcCtD
Risperidone—Body temperature increased—Vincristine—colon cancer	0.000171	0.00067	CcSEcCtD
Risperidone—Flatulence—Capecitabine—colon cancer	0.000171	0.000667	CcSEcCtD
Risperidone—Erectile dysfunction—Methotrexate—colon cancer	0.00017	0.000667	CcSEcCtD
Risperidone—Dysgeusia—Capecitabine—colon cancer	0.00017	0.000663	CcSEcCtD
Risperidone—Photosensitivity reaction—Methotrexate—colon cancer	0.000169	0.000661	CcSEcCtD
Risperidone—Back pain—Capecitabine—colon cancer	0.000168	0.000655	CcSEcCtD
Risperidone—Abdominal pain—Irinotecan—colon cancer	0.000167	0.000653	CcSEcCtD
Risperidone—Body temperature increased—Irinotecan—colon cancer	0.000167	0.000653	CcSEcCtD
Risperidone—Feeling abnormal—Fluorouracil—colon cancer	0.000167	0.000652	CcSEcCtD
Risperidone—Muscle spasms—Capecitabine—colon cancer	0.000167	0.000651	CcSEcCtD
Risperidone—Pneumonia—Methotrexate—colon cancer	0.000166	0.000649	CcSEcCtD
Risperidone—Infestation—Methotrexate—colon cancer	0.000165	0.000645	CcSEcCtD
Risperidone—Infestation NOS—Methotrexate—colon cancer	0.000165	0.000645	CcSEcCtD
Risperidone—Drowsiness—Methotrexate—colon cancer	0.000165	0.000645	CcSEcCtD
Risperidone—Depression—Methotrexate—colon cancer	0.000165	0.000643	CcSEcCtD
Risperidone—ABCB1—lymph node—colon cancer	0.000164	0.00204	CbGeAlD
Risperidone—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000164	0.00064	CcSEcCtD
Risperidone—Vision blurred—Capecitabine—colon cancer	0.000163	0.000638	CcSEcCtD
Risperidone—Tremor—Capecitabine—colon cancer	0.000162	0.000635	CcSEcCtD
Risperidone—Renal failure—Methotrexate—colon cancer	0.000162	0.000634	CcSEcCtD
Risperidone—Stomatitis—Methotrexate—colon cancer	0.000161	0.000629	CcSEcCtD
Risperidone—Ill-defined disorder—Capecitabine—colon cancer	0.000161	0.000628	CcSEcCtD
Risperidone—Urticaria—Fluorouracil—colon cancer	0.000161	0.000628	CcSEcCtD
Risperidone—Conjunctivitis—Methotrexate—colon cancer	0.00016	0.000627	CcSEcCtD
Risperidone—Anaemia—Capecitabine—colon cancer	0.00016	0.000626	CcSEcCtD
Risperidone—Body temperature increased—Fluorouracil—colon cancer	0.00016	0.000625	CcSEcCtD
Risperidone—Hypersensitivity—Vincristine—colon cancer	0.00016	0.000625	CcSEcCtD
Risperidone—Sweating—Methotrexate—colon cancer	0.000158	0.000619	CcSEcCtD
Risperidone—Haematuria—Methotrexate—colon cancer	0.000157	0.000615	CcSEcCtD
Risperidone—Malaise—Capecitabine—colon cancer	0.000156	0.000611	CcSEcCtD
Risperidone—Hepatobiliary disease—Methotrexate—colon cancer	0.000156	0.00061	CcSEcCtD
Risperidone—Epistaxis—Methotrexate—colon cancer	0.000156	0.000609	CcSEcCtD
Risperidone—Vertigo—Capecitabine—colon cancer	0.000156	0.000609	CcSEcCtD
Risperidone—Hypersensitivity—Irinotecan—colon cancer	0.000156	0.000609	CcSEcCtD
Risperidone—Asthenia—Vincristine—colon cancer	0.000156	0.000609	CcSEcCtD
Risperidone—Syncope—Capecitabine—colon cancer	0.000155	0.000607	CcSEcCtD
Risperidone—Leukopenia—Capecitabine—colon cancer	0.000155	0.000606	CcSEcCtD
Risperidone—Agranulocytosis—Methotrexate—colon cancer	0.000154	0.000602	CcSEcCtD
Risperidone—Palpitations—Capecitabine—colon cancer	0.000153	0.000599	CcSEcCtD
Risperidone—Loss of consciousness—Capecitabine—colon cancer	0.000152	0.000595	CcSEcCtD
Risperidone—Asthenia—Irinotecan—colon cancer	0.000152	0.000593	CcSEcCtD
Risperidone—Cough—Capecitabine—colon cancer	0.000151	0.000591	CcSEcCtD
Risperidone—Hypertension—Capecitabine—colon cancer	0.00015	0.000585	CcSEcCtD
Risperidone—Hypersensitivity—Fluorouracil—colon cancer	0.000149	0.000583	CcSEcCtD
Risperidone—Haemoglobin—Methotrexate—colon cancer	0.000149	0.000582	CcSEcCtD
Risperidone—Diarrhoea—Vincristine—colon cancer	0.000148	0.00058	CcSEcCtD
Risperidone—Hepatitis—Methotrexate—colon cancer	0.000148	0.000579	CcSEcCtD
Risperidone—Haemorrhage—Methotrexate—colon cancer	0.000148	0.000579	CcSEcCtD
Risperidone—Chest pain—Capecitabine—colon cancer	0.000147	0.000577	CcSEcCtD
Risperidone—Arthralgia—Capecitabine—colon cancer	0.000147	0.000577	CcSEcCtD
Risperidone—Myalgia—Capecitabine—colon cancer	0.000147	0.000577	CcSEcCtD
Risperidone—Pharyngitis—Methotrexate—colon cancer	0.000147	0.000575	CcSEcCtD
Risperidone—Anxiety—Capecitabine—colon cancer	0.000147	0.000575	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000146	0.000573	CcSEcCtD
Risperidone—Urinary tract disorder—Methotrexate—colon cancer	0.000146	0.000572	CcSEcCtD
Risperidone—Discomfort—Capecitabine—colon cancer	0.000146	0.00057	CcSEcCtD
Risperidone—Urethral disorder—Methotrexate—colon cancer	0.000145	0.000568	CcSEcCtD
Risperidone—Diarrhoea—Irinotecan—colon cancer	0.000145	0.000565	CcSEcCtD
Risperidone—Dry mouth—Capecitabine—colon cancer	0.000144	0.000564	CcSEcCtD
Risperidone—Dizziness—Vincristine—colon cancer	0.000143	0.000561	CcSEcCtD
Risperidone—Pruritus—Fluorouracil—colon cancer	0.000143	0.00056	CcSEcCtD
Risperidone—Visual impairment—Methotrexate—colon cancer	0.000143	0.000558	CcSEcCtD
Risperidone—Confusional state—Capecitabine—colon cancer	0.000143	0.000557	CcSEcCtD
Risperidone—Oedema—Capecitabine—colon cancer	0.000141	0.000553	CcSEcCtD
Risperidone—Infection—Capecitabine—colon cancer	0.00014	0.000549	CcSEcCtD
Risperidone—Erythema multiforme—Methotrexate—colon cancer	0.00014	0.000548	CcSEcCtD
Risperidone—Dizziness—Irinotecan—colon cancer	0.00014	0.000546	CcSEcCtD
Risperidone—Shock—Capecitabine—colon cancer	0.000139	0.000544	CcSEcCtD
Risperidone—Nervous system disorder—Capecitabine—colon cancer	0.000139	0.000542	CcSEcCtD
Risperidone—Eye disorder—Methotrexate—colon cancer	0.000138	0.000541	CcSEcCtD
Risperidone—Diarrhoea—Fluorouracil—colon cancer	0.000138	0.000541	CcSEcCtD
Risperidone—Thrombocytopenia—Capecitabine—colon cancer	0.000138	0.000541	CcSEcCtD
Risperidone—Tinnitus—Methotrexate—colon cancer	0.000138	0.00054	CcSEcCtD
Risperidone—Tachycardia—Capecitabine—colon cancer	0.000138	0.00054	CcSEcCtD
Risperidone—Vomiting—Vincristine—colon cancer	0.000138	0.000539	CcSEcCtD
Risperidone—Cardiac disorder—Methotrexate—colon cancer	0.000137	0.000538	CcSEcCtD
Risperidone—Skin disorder—Capecitabine—colon cancer	0.000137	0.000537	CcSEcCtD
Risperidone—Rash—Vincristine—colon cancer	0.000137	0.000535	CcSEcCtD
Risperidone—Hyperhidrosis—Capecitabine—colon cancer	0.000137	0.000534	CcSEcCtD
Risperidone—Dermatitis—Vincristine—colon cancer	0.000137	0.000534	CcSEcCtD
Risperidone—Headache—Vincristine—colon cancer	0.000136	0.000531	CcSEcCtD
Risperidone—Anorexia—Capecitabine—colon cancer	0.000135	0.000527	CcSEcCtD
Risperidone—Angiopathy—Methotrexate—colon cancer	0.000134	0.000526	CcSEcCtD
Risperidone—Vomiting—Irinotecan—colon cancer	0.000134	0.000525	CcSEcCtD
Risperidone—Immune system disorder—Methotrexate—colon cancer	0.000134	0.000523	CcSEcCtD
Risperidone—Dizziness—Fluorouracil—colon cancer	0.000134	0.000523	CcSEcCtD
Risperidone—Mediastinal disorder—Methotrexate—colon cancer	0.000134	0.000522	CcSEcCtD
Risperidone—Rash—Irinotecan—colon cancer	0.000133	0.000521	CcSEcCtD
Risperidone—Dermatitis—Irinotecan—colon cancer	0.000133	0.00052	CcSEcCtD
Risperidone—Chills—Methotrexate—colon cancer	0.000133	0.00052	CcSEcCtD
Risperidone—Headache—Irinotecan—colon cancer	0.000132	0.000517	CcSEcCtD
Risperidone—Hypotension—Capecitabine—colon cancer	0.000132	0.000517	CcSEcCtD
Risperidone—Alopecia—Methotrexate—colon cancer	0.000131	0.000512	CcSEcCtD
Risperidone—Mental disorder—Methotrexate—colon cancer	0.00013	0.000507	CcSEcCtD
Risperidone—Malnutrition—Methotrexate—colon cancer	0.000129	0.000504	CcSEcCtD
Risperidone—Erythema—Methotrexate—colon cancer	0.000129	0.000504	CcSEcCtD
Risperidone—Nausea—Vincristine—colon cancer	0.000129	0.000504	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000129	0.000504	CcSEcCtD
Risperidone—Vomiting—Fluorouracil—colon cancer	0.000129	0.000503	CcSEcCtD
Risperidone—Insomnia—Capecitabine—colon cancer	0.000128	0.0005	CcSEcCtD
Risperidone—Rash—Fluorouracil—colon cancer	0.000128	0.000499	CcSEcCtD
Risperidone—Dermatitis—Fluorouracil—colon cancer	0.000127	0.000498	CcSEcCtD
Risperidone—Paraesthesia—Capecitabine—colon cancer	0.000127	0.000496	CcSEcCtD
Risperidone—Headache—Fluorouracil—colon cancer	0.000127	0.000496	CcSEcCtD
Risperidone—Dysgeusia—Methotrexate—colon cancer	0.000126	0.000494	CcSEcCtD
Risperidone—Dyspnoea—Capecitabine—colon cancer	0.000126	0.000493	CcSEcCtD
Risperidone—Nausea—Irinotecan—colon cancer	0.000125	0.000491	CcSEcCtD
Risperidone—Back pain—Methotrexate—colon cancer	0.000125	0.000488	CcSEcCtD
Risperidone—Dyspepsia—Capecitabine—colon cancer	0.000124	0.000487	CcSEcCtD
Risperidone—Decreased appetite—Capecitabine—colon cancer	0.000123	0.000481	CcSEcCtD
Risperidone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000122	0.000477	CcSEcCtD
Risperidone—Fatigue—Capecitabine—colon cancer	0.000122	0.000477	CcSEcCtD
Risperidone—Vision blurred—Methotrexate—colon cancer	0.000122	0.000475	CcSEcCtD
Risperidone—Pain—Capecitabine—colon cancer	0.000121	0.000473	CcSEcCtD
Risperidone—Constipation—Capecitabine—colon cancer	0.000121	0.000473	CcSEcCtD
Risperidone—Nausea—Fluorouracil—colon cancer	0.00012	0.00047	CcSEcCtD
Risperidone—Ill-defined disorder—Methotrexate—colon cancer	0.00012	0.000468	CcSEcCtD
Risperidone—Anaemia—Methotrexate—colon cancer	0.000119	0.000466	CcSEcCtD
Risperidone—Feeling abnormal—Capecitabine—colon cancer	0.000117	0.000456	CcSEcCtD
Risperidone—Malaise—Methotrexate—colon cancer	0.000116	0.000455	CcSEcCtD
Risperidone—Vertigo—Methotrexate—colon cancer	0.000116	0.000453	CcSEcCtD
Risperidone—Gastrointestinal pain—Capecitabine—colon cancer	0.000116	0.000452	CcSEcCtD
Risperidone—Leukopenia—Methotrexate—colon cancer	0.000115	0.000451	CcSEcCtD
Risperidone—Cough—Methotrexate—colon cancer	0.000113	0.00044	CcSEcCtD
Risperidone—Urticaria—Capecitabine—colon cancer	0.000112	0.000439	CcSEcCtD
Risperidone—Abdominal pain—Capecitabine—colon cancer	0.000112	0.000437	CcSEcCtD
Risperidone—Body temperature increased—Capecitabine—colon cancer	0.000112	0.000437	CcSEcCtD
Risperidone—Convulsion—Methotrexate—colon cancer	0.000112	0.000437	CcSEcCtD
Risperidone—Arthralgia—Methotrexate—colon cancer	0.00011	0.000429	CcSEcCtD
Risperidone—Chest pain—Methotrexate—colon cancer	0.00011	0.000429	CcSEcCtD
Risperidone—Myalgia—Methotrexate—colon cancer	0.00011	0.000429	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000109	0.000426	CcSEcCtD
Risperidone—Discomfort—Methotrexate—colon cancer	0.000108	0.000424	CcSEcCtD
Risperidone—Confusional state—Methotrexate—colon cancer	0.000106	0.000415	CcSEcCtD
Risperidone—Anaphylactic shock—Methotrexate—colon cancer	0.000105	0.000412	CcSEcCtD
Risperidone—Infection—Methotrexate—colon cancer	0.000105	0.000409	CcSEcCtD
Risperidone—Hypersensitivity—Capecitabine—colon cancer	0.000104	0.000407	CcSEcCtD
Risperidone—Nervous system disorder—Methotrexate—colon cancer	0.000103	0.000404	CcSEcCtD
Risperidone—Thrombocytopenia—Methotrexate—colon cancer	0.000103	0.000403	CcSEcCtD
Risperidone—Skin disorder—Methotrexate—colon cancer	0.000102	0.0004	CcSEcCtD
Risperidone—Hyperhidrosis—Methotrexate—colon cancer	0.000102	0.000398	CcSEcCtD
Risperidone—Asthenia—Capecitabine—colon cancer	0.000101	0.000397	CcSEcCtD
Risperidone—Anorexia—Methotrexate—colon cancer	0.0001	0.000392	CcSEcCtD
Risperidone—Pruritus—Capecitabine—colon cancer	0.0001	0.000391	CcSEcCtD
Risperidone—Hypotension—Methotrexate—colon cancer	9.84e-05	0.000385	CcSEcCtD
Risperidone—Diarrhoea—Capecitabine—colon cancer	9.67e-05	0.000378	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methotrexate—colon cancer	9.59e-05	0.000375	CcSEcCtD
Risperidone—Insomnia—Methotrexate—colon cancer	9.52e-05	0.000372	CcSEcCtD
Risperidone—Paraesthesia—Methotrexate—colon cancer	9.45e-05	0.00037	CcSEcCtD
Risperidone—Dyspnoea—Methotrexate—colon cancer	9.38e-05	0.000367	CcSEcCtD
Risperidone—Somnolence—Methotrexate—colon cancer	9.36e-05	0.000366	CcSEcCtD
Risperidone—Dizziness—Capecitabine—colon cancer	9.35e-05	0.000366	CcSEcCtD
Risperidone—Dyspepsia—Methotrexate—colon cancer	9.27e-05	0.000362	CcSEcCtD
Risperidone—Decreased appetite—Methotrexate—colon cancer	9.15e-05	0.000358	CcSEcCtD
Risperidone—Gastrointestinal disorder—Methotrexate—colon cancer	9.09e-05	0.000355	CcSEcCtD
Risperidone—Fatigue—Methotrexate—colon cancer	9.07e-05	0.000355	CcSEcCtD
Risperidone—Pain—Methotrexate—colon cancer	9e-05	0.000352	CcSEcCtD
Risperidone—Vomiting—Capecitabine—colon cancer	8.99e-05	0.000351	CcSEcCtD
Risperidone—Rash—Capecitabine—colon cancer	8.92e-05	0.000349	CcSEcCtD
Risperidone—Dermatitis—Capecitabine—colon cancer	8.91e-05	0.000348	CcSEcCtD
Risperidone—Headache—Capecitabine—colon cancer	8.86e-05	0.000346	CcSEcCtD
Risperidone—Feeling abnormal—Methotrexate—colon cancer	8.67e-05	0.000339	CcSEcCtD
Risperidone—Gastrointestinal pain—Methotrexate—colon cancer	8.61e-05	0.000337	CcSEcCtD
Risperidone—Nausea—Capecitabine—colon cancer	8.4e-05	0.000328	CcSEcCtD
Risperidone—Urticaria—Methotrexate—colon cancer	8.36e-05	0.000327	CcSEcCtD
Risperidone—Abdominal pain—Methotrexate—colon cancer	8.32e-05	0.000325	CcSEcCtD
Risperidone—Body temperature increased—Methotrexate—colon cancer	8.32e-05	0.000325	CcSEcCtD
Risperidone—Hypersensitivity—Methotrexate—colon cancer	7.75e-05	0.000303	CcSEcCtD
Risperidone—Asthenia—Methotrexate—colon cancer	7.55e-05	0.000295	CcSEcCtD
Risperidone—Pruritus—Methotrexate—colon cancer	7.45e-05	0.000291	CcSEcCtD
Risperidone—Diarrhoea—Methotrexate—colon cancer	7.2e-05	0.000282	CcSEcCtD
Risperidone—Dizziness—Methotrexate—colon cancer	6.96e-05	0.000272	CcSEcCtD
Risperidone—Vomiting—Methotrexate—colon cancer	6.69e-05	0.000262	CcSEcCtD
Risperidone—Rash—Methotrexate—colon cancer	6.64e-05	0.000259	CcSEcCtD
Risperidone—Dermatitis—Methotrexate—colon cancer	6.63e-05	0.000259	CcSEcCtD
Risperidone—Headache—Methotrexate—colon cancer	6.59e-05	0.000258	CcSEcCtD
Risperidone—Nausea—Methotrexate—colon cancer	6.25e-05	0.000244	CcSEcCtD
Risperidone—HTR2C—Signaling Pathways—CCND1—colon cancer	2.39e-07	0.00022	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—colon cancer	2.39e-07	0.00022	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PIK3CA—colon cancer	2.39e-07	0.00022	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—KRAS—colon cancer	2.39e-07	0.00022	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CTNNB1—colon cancer	2.38e-07	0.000219	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—colon cancer	2.38e-07	0.000219	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NRAS—colon cancer	2.37e-07	0.000218	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—colon cancer	2.37e-07	0.000218	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—colon cancer	2.37e-07	0.000218	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—KRAS—colon cancer	2.37e-07	0.000218	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CTNNB1—colon cancer	2.37e-07	0.000218	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—colon cancer	2.35e-07	0.000216	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—colon cancer	2.34e-07	0.000216	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PIK3CA—colon cancer	2.34e-07	0.000216	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—KRAS—colon cancer	2.34e-07	0.000215	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCND1—colon cancer	2.32e-07	0.000214	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—colon cancer	2.32e-07	0.000214	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CDKN1A—colon cancer	2.32e-07	0.000214	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CDKN1A—colon cancer	2.31e-07	0.000213	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CTNNB1—colon cancer	2.3e-07	0.000212	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—KRAS—colon cancer	2.3e-07	0.000212	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EP300—colon cancer	2.29e-07	0.000211	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—colon cancer	2.29e-07	0.000211	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCND1—colon cancer	2.29e-07	0.000211	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CTNNB1—colon cancer	2.27e-07	0.000209	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—colon cancer	2.26e-07	0.000208	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—colon cancer	2.25e-07	0.000207	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HRAS—colon cancer	2.25e-07	0.000207	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CDKN1A—colon cancer	2.25e-07	0.000207	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—colon cancer	2.24e-07	0.000206	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—colon cancer	2.24e-07	0.000206	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SRC—colon cancer	2.23e-07	0.000205	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—HRAS—colon cancer	2.21e-07	0.000204	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CDKN1A—colon cancer	2.21e-07	0.000204	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EP300—colon cancer	2.21e-07	0.000204	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—colon cancer	2.21e-07	0.000203	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HRAS—colon cancer	2.21e-07	0.000203	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PIK3CA—colon cancer	2.21e-07	0.000203	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—colon cancer	2.21e-07	0.000203	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EP300—colon cancer	2.2e-07	0.000202	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARG—colon cancer	2.2e-07	0.000202	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—KRAS—colon cancer	2.2e-07	0.000202	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PIK3CA—colon cancer	2.19e-07	0.000202	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—colon cancer	2.19e-07	0.000202	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—colon cancer	2.19e-07	0.000201	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—colon cancer	2.19e-07	0.000201	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PIK3CA—colon cancer	2.18e-07	0.0002	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—colon cancer	2.17e-07	0.0002	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HRAS—colon cancer	2.17e-07	0.000199	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—colon cancer	2.17e-07	0.000199	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—colon cancer	2.16e-07	0.000199	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—colon cancer	2.15e-07	0.000198	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—colon cancer	2.15e-07	0.000198	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SRC—colon cancer	2.15e-07	0.000198	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—colon cancer	2.15e-07	0.000198	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PIK3CA—colon cancer	2.15e-07	0.000198	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NRAS—colon cancer	2.14e-07	0.000197	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EP300—colon cancer	2.14e-07	0.000197	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SRC—colon cancer	2.14e-07	0.000197	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—colon cancer	2.14e-07	0.000197	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—colon cancer	2.13e-07	0.000196	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—colon cancer	2.13e-07	0.000196	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—colon cancer	2.12e-07	0.000195	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PIK3CA—colon cancer	2.11e-07	0.000194	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—colon cancer	2.11e-07	0.000194	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—colon cancer	2.11e-07	0.000194	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EP300—colon cancer	2.11e-07	0.000194	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—colon cancer	2.09e-07	0.000193	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CTNNB1—colon cancer	2.09e-07	0.000192	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—colon cancer	2.09e-07	0.000192	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—colon cancer	2.08e-07	0.000192	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SRC—colon cancer	2.08e-07	0.000191	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—EP300—colon cancer	2.08e-07	0.000191	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—colon cancer	2.08e-07	0.000191	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—colon cancer	2.08e-07	0.000191	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—colon cancer	2.07e-07	0.000191	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KRAS—colon cancer	2.07e-07	0.000191	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARG—colon cancer	2.07e-07	0.000191	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NRAS—colon cancer	2.07e-07	0.00019	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NRAS—colon cancer	2.06e-07	0.000189	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—colon cancer	2.06e-07	0.000189	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—colon cancer	2.05e-07	0.000189	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SRC—colon cancer	2.05e-07	0.000188	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—colon cancer	2.04e-07	0.000188	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KRAS—colon cancer	2.04e-07	0.000188	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HRAS—colon cancer	2.04e-07	0.000188	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CDKN1A—colon cancer	2.04e-07	0.000188	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—colon cancer	2.03e-07	0.000187	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HRAS—colon cancer	2.03e-07	0.000187	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—colon cancer	2.03e-07	0.000187	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—colon cancer	2.02e-07	0.000186	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HRAS—colon cancer	2.01e-07	0.000185	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—colon cancer	2.01e-07	0.000185	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CDKN1A—colon cancer	2.01e-07	0.000185	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CDKN1A—colon cancer	2e-07	0.000184	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NRAS—colon cancer	2e-07	0.000184	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—colon cancer	2e-07	0.000184	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—colon cancer	1.99e-07	0.000184	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—colon cancer	1.99e-07	0.000183	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HRAS—colon cancer	1.99e-07	0.000183	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—colon cancer	1.99e-07	0.000183	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NRAS—colon cancer	1.97e-07	0.000181	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDKN1A—colon cancer	1.97e-07	0.000181	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—colon cancer	1.96e-07	0.00018	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HRAS—colon cancer	1.95e-07	0.00018	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—colon cancer	1.95e-07	0.00018	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—colon cancer	1.95e-07	0.00018	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—colon cancer	1.95e-07	0.00018	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—colon cancer	1.95e-07	0.000179	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—colon cancer	1.95e-07	0.000179	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCB1—colon cancer	1.95e-07	0.000179	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EP300—colon cancer	1.94e-07	0.000179	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—colon cancer	1.94e-07	0.000179	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—colon cancer	1.93e-07	0.000177	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—colon cancer	1.92e-07	0.000177	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—colon cancer	1.92e-07	0.000176	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—colon cancer	1.91e-07	0.000176	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—colon cancer	1.91e-07	0.000176	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—TYMS—colon cancer	1.91e-07	0.000176	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EP300—colon cancer	1.91e-07	0.000176	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EP300—colon cancer	1.91e-07	0.000175	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—EP300—colon cancer	1.9e-07	0.000175	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—colon cancer	1.9e-07	0.000175	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—colon cancer	1.89e-07	0.000174	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—colon cancer	1.89e-07	0.000174	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SRC—colon cancer	1.89e-07	0.000174	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—colon cancer	1.88e-07	0.000173	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—colon cancer	1.88e-07	0.000173	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—colon cancer	1.87e-07	0.000173	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EP300—colon cancer	1.87e-07	0.000172	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—colon cancer	1.87e-07	0.000172	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HRAS—colon cancer	1.87e-07	0.000172	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—colon cancer	1.86e-07	0.000172	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—colon cancer	1.86e-07	0.000171	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SRC—colon cancer	1.86e-07	0.000171	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SRC—colon cancer	1.85e-07	0.000171	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KRAS—colon cancer	1.84e-07	0.00017	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—colon cancer	1.84e-07	0.000169	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—colon cancer	1.84e-07	0.000169	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—colon cancer	1.83e-07	0.000169	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—colon cancer	1.83e-07	0.000168	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1A—colon cancer	1.83e-07	0.000168	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—colon cancer	1.82e-07	0.000168	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SRC—colon cancer	1.82e-07	0.000167	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NRAS—colon cancer	1.82e-07	0.000167	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—colon cancer	1.82e-07	0.000167	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—colon cancer	1.81e-07	0.000167	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—colon cancer	1.81e-07	0.000166	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—colon cancer	1.8e-07	0.000166	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—colon cancer	1.79e-07	0.000165	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—colon cancer	1.79e-07	0.000165	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NRAS—colon cancer	1.79e-07	0.000164	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NRAS—colon cancer	1.78e-07	0.000164	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KRAS—colon cancer	1.78e-07	0.000164	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—colon cancer	1.78e-07	0.000164	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—colon cancer	1.77e-07	0.000163	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KRAS—colon cancer	1.77e-07	0.000163	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HRAS—colon cancer	1.76e-07	0.000162	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—colon cancer	1.75e-07	0.000161	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NRAS—colon cancer	1.75e-07	0.000161	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EP300—colon cancer	1.74e-07	0.00016	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HRAS—colon cancer	1.74e-07	0.00016	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—colon cancer	1.73e-07	0.000159	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—colon cancer	1.73e-07	0.000159	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KRAS—colon cancer	1.72e-07	0.000159	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KRAS—colon cancer	1.7e-07	0.000156	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—colon cancer	1.69e-07	0.000156	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—colon cancer	1.69e-07	0.000156	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SRC—colon cancer	1.69e-07	0.000156	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—colon cancer	1.69e-07	0.000155	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—colon cancer	1.66e-07	0.000153	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—colon cancer	1.66e-07	0.000153	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—colon cancer	1.66e-07	0.000153	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—colon cancer	1.66e-07	0.000153	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—colon cancer	1.65e-07	0.000152	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—colon cancer	1.65e-07	0.000152	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—colon cancer	1.65e-07	0.000151	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—colon cancer	1.64e-07	0.000151	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—colon cancer	1.64e-07	0.000151	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—colon cancer	1.63e-07	0.00015	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—colon cancer	1.63e-07	0.00015	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—colon cancer	1.63e-07	0.00015	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—colon cancer	1.63e-07	0.00015	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—colon cancer	1.63e-07	0.00015	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NRAS—colon cancer	1.63e-07	0.00015	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—colon cancer	1.62e-07	0.00015	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—colon cancer	1.59e-07	0.000147	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—colon cancer	1.59e-07	0.000147	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—colon cancer	1.58e-07	0.000146	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—colon cancer	1.58e-07	0.000146	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—colon cancer	1.57e-07	0.000145	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HRAS—colon cancer	1.57e-07	0.000144	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KRAS—colon cancer	1.56e-07	0.000144	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—colon cancer	1.56e-07	0.000143	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—colon cancer	1.55e-07	0.000143	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—colon cancer	1.55e-07	0.000142	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KRAS—colon cancer	1.54e-07	0.000142	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—colon cancer	1.54e-07	0.000142	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KRAS—colon cancer	1.53e-07	0.000141	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—colon cancer	1.53e-07	0.000141	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—colon cancer	1.53e-07	0.000141	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—colon cancer	1.51e-07	0.000139	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HRAS—colon cancer	1.51e-07	0.000139	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—colon cancer	1.51e-07	0.000139	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—colon cancer	1.51e-07	0.000139	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KRAS—colon cancer	1.51e-07	0.000139	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HRAS—colon cancer	1.51e-07	0.000139	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—colon cancer	1.48e-07	0.000136	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HRAS—colon cancer	1.46e-07	0.000135	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HRAS—colon cancer	1.44e-07	0.000133	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—EP300—colon cancer	1.44e-07	0.000132	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—colon cancer	1.44e-07	0.000132	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—colon cancer	1.41e-07	0.00013	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—colon cancer	1.41e-07	0.00013	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—colon cancer	1.41e-07	0.00013	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KRAS—colon cancer	1.4e-07	0.000129	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—colon cancer	1.39e-07	0.000128	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—colon cancer	1.38e-07	0.000127	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—colon cancer	1.38e-07	0.000127	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—colon cancer	1.37e-07	0.000126	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—colon cancer	1.36e-07	0.000126	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—EP300—colon cancer	1.35e-07	0.000125	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARG—colon cancer	1.35e-07	0.000125	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—colon cancer	1.34e-07	0.000123	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—colon cancer	1.34e-07	0.000123	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—colon cancer	1.33e-07	0.000122	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HRAS—colon cancer	1.33e-07	0.000122	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HRAS—colon cancer	1.31e-07	0.00012	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HRAS—colon cancer	1.3e-07	0.00012	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—colon cancer	1.29e-07	0.000119	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—colon cancer	1.29e-07	0.000118	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HRAS—colon cancer	1.28e-07	0.000118	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—colon cancer	1.27e-07	0.000117	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—colon cancer	1.26e-07	0.000116	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—colon cancer	1.24e-07	0.000114	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HRAS—colon cancer	1.19e-07	0.000109	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—colon cancer	1.17e-07	0.000108	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—colon cancer	1.15e-07	0.000106	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—colon cancer	1.15e-07	0.000106	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—colon cancer	1.15e-07	0.000106	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—colon cancer	1.13e-07	0.000104	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—colon cancer	1.06e-07	9.8e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—colon cancer	1.06e-07	9.78e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—colon cancer	1.05e-07	9.67e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—colon cancer	1e-07	9.22e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—EP300—colon cancer	8.85e-08	8.15e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—colon cancer	8.69e-08	7.99e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—colon cancer	8.18e-08	7.53e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—colon cancer	6.55e-08	6.03e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—colon cancer	5.35e-08	4.92e-05	CbGpPWpGaD
